Literature DB >> 1909174

Serum response factor affects preinitiation complex formation by TFIID in vitro.

H Zhu1, A L Roy, R G Roeder, R Prywes.   

Abstract

Serum response factor (SRF), a transcription factor that binds to the serum response element (SRE) of the c-fos proto-oncogene, activates transcription of an SRE-containing reporter plasmid in vitro. We describe here preincubation experiments which indicate that SRF activates transcription by facilitating the formation of active preinitiation complexes. Full activation by SRF occurred if SRF was preincubated with the general transcription factors. However, if the general transcription factors were preincubated and SRF was added subsequently, only poor activation of transcription was observed. This suggests that SRF must be present during preinitiation complex formation and that this complex is refractory to activation if SRF is absent during its formation. We have fractionated the general transcription factors and found that only a highly purified fraction containing the TATA-binding factor TFIID (and other unidentified components) must be present during preincubation for maximal transcriptional induction by SRF. This supports a model in which SRF activates transcription by affecting the conformation of TFIID bound to the promoter. Also of interest was the finding that recombinant human TFIID expressed in bacteria cannot mediate SRF-activated transcription, although it does support basal transcription. These results suggest that SRF may affect TFIID via a cofactor or coactivator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909174

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  13 in total

1.  Analysis of fra-2 gene expression.

Authors:  T Yoshida; T Suzuki; H Sato; H Nishina; H Iba
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

2.  Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts.

Authors:  C Gauthier-Rouviere; M Vandromme; D Tuil; N Lautredou; M Morris; M Soulez; A Kahn; A Fernandez; N Lamb
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

3.  Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators.

Authors:  N S Belaguli; J L Sepulveda; V Nigam; F Charron; M Nemer; R J Schwartz
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.

Authors:  N S Belaguli; W Zhou; T H Trinh; M W Majesky; R J Schwartz
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs.

Authors:  F E Johansen; R Prywes
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts.

Authors:  T C Lee; Y Shi; R J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Purified cofactors and histone H1 mediate transcriptional regulation by CTF/NF-I.

Authors:  Y Dusserre; N Mermod
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators.

Authors:  R Prywes; H Zhu
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

9.  Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein.

Authors:  A M Boulden; L J Sealy
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

10.  Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid.

Authors:  R L Widom; M Rhee; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.